Ralph Giacobbe

"While uncertainty around the CIGNA Corporation (NYSE: CI) deal has weighed on Anthem Inc (NYSE: ANTM) shares of late, we believe concern around Exchanges has also held back the stock," Citi analyst Ralph Giacobbe reassured investors in a note Monday. The analyst's claim followed...

Tenet Healthcare Corp (NYSE: THC) shares are down more than 10 percent year-to-date despite a favorable outlook, an analyst said Tuesday. Worries regarding a pending Supreme Court decision on the Affordable Care Act, as well as unmet high expectations have pressured the hospital chain since it...

In a report published Monday, Credit Suisse analyst Ralph Giacobbe reiterated an Outperform rating on Aetna Inc. (NYSE: AET), and raised the price target from $103.00 to $112.00. In the report, Credit Suisse noted, "We recently hosted investor meetings with AET mgmt including CEO Mark Bertolini and...

In a report published Wednesday, Credit Suisse analyst Ralph Giacobbe reiterated an Outperform rating on HCA Holdings (NYSE: HCA), but lowered the price target from $83.00 to $81.00. In the report, Credit Suisse noted, "With 4Q results in-line with preannouncement in early January, focus was on...

In a report published Thursday, Credit Suisse analyst Ralph Giacobbe reiterated an Outperform rating on Community Health Systems (NYSE: CYH), and raised the price target from $63.00 to $66.00. In the report, Credit Suisse noted, “We are increasing our TP for CYH to $66 (from $63), which pegs an ~8....

In a report published Thursday, Credit Suisse analyst Ralph Giacobbe reiterated an Outperform rating on HCA Holdings (NYSE: HCA), and raised the price target from $81.00 to $83.00. In the report, Credit Suisse noted, “We are increasing our TP for HCA to $83 (from $81), which pegs a ~9x multiple on...

In a report published Thursday, Credit Suisse analyst Ralph Giacobbe reiterated an Outperform rating on Universal Health Services, Inc. (NYSE: UHS), and raised the price target from $118.00 to $124.00. In the report, Credit Suisse noted, “We are increasing our TP for UHS to $124 (from $...

In a report published Tuesday, Credit Suisse analyst Ralph Giacobbe upgraded the rating on LHC Group (NASDAQ: LHCG) from Underperform to Outperform, and raised the price target from $22.00 to $32.00. In the report, Credit Suisse noted, “Upgrading LHCG to Outperform (from Underperform), raising...

In a report published Wednesday, Credit Suisse analyst Ralph Giacobbe reiterated an Outperform rating on UnitedHealth Group Inc. (NYSE: UNH), and raised the price target from $95.00 to $110.00. In the report, Credit Suisse noted, “UNH hosted its annual Investor Day in NY and provided detailed 2015...

Humana Inc's (NYSE: HUM) business fundamentals are solid despite its 19 percent decline in third-quarter earnings, an analyst said Monday. Its shares took a significant hit Friday when it posted quarterly results and offered a 2015 outlook below expectations. Humana traded recently at $132....

In a report published Monday, Credit Suisse analyst Ralph Giacobbe reiterated a Neutral rating on Humana Inc (NYSE: HUM), and raised the price target from $123.00 to $140.00. In the report, Credit Suisse noted, “We have revisited our HUM model following 3Q14 results. We have lowered our 2014E EPS...

In a report published Friday, Credit Suisse analyst Ralph Giacobbe reiterated an Outperform rating on CIGNA Corporation (NYSE: CI), and raised the price target from $97.00 to $105.00. In the report, Credit Suisse noted, “We hosted investor meetings with CI through Boston yesterday. We would...